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Abstract
Background: Depression is highly prevalent, but knowledge is scarce as to whether increased public awareness
and strengthened government focus on mental health have changed how general practitioners (GPs) help their
depressed patients. This study aimed to examine national time trends in GP depression care and whether trends
varied regarding patient gender, age, and comorbidity.
Methods: Nationwide registry-based cohort study, Norway. The study population comprised all residents aged 20
years or older with new depression diagnoses recorded in general practice, 2009–2015. We linked reimbursement
claims data from all consultations in general practice for depression with information on demographics and
antidepressant medication. The outcome was type(s) of GP depression care during 12 months from the date of
diagnosis: (long) consultation, talking therapy, antidepressant drug treatment, sickness absence certification, and
referral to secondary mental health care. Covariates were patient gender, age, and comorbidity. The data are
presented as frequencies and tested with generalized linear models.
Results: We included 365,947 new depression diagnoses. Mean patient age was 44 years (SD = 16), 61.9 % were women,
41.2 % had comorbidity. From 2009 to 2015, proportions of patients receiving talking therapy (42.3–63.4 %), long
consultations (56.4–71.8 %), and referral to secondary care (16.6–21.6 %) increased, while those receiving drug treatment
(31.3–25.9 %) and sick-listing (58.1–50%) decreased. The trends were different for gender (women had a greater increase
in talking therapy and a smaller decrease in sick-listing, compared to men), age (working-aged patients had a smaller
increase in talking therapy, a greater increase in long consultations, and a smaller decrease in antidepressant drug use,
compared to older patients) and comorbidity (patients with mental comorbidity had a smaller increase in talking therapy
and a greater increase in long consultations, compared to those with no comorbidity and somatic comorbidity).
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Conclusions: The observed time trends in GP depression care towards increased provision of psychological treatment
and less drug treatment and sick-listing were in the desired direction according to Norwegian health care policy.
However, the large and persistent differences in treatment rates between working-aged and older patients needs further
investigation.
Keywords: Depression, General practice, Mental health, Drug therapy, Psychotherapy, Secondary care, Sick leave, Health
services research, Large database research
Background
Depression is among the three leading causes of years
lived with disability (YLD) globally, at great personal and
societal costs [1]. The ECNP/EBC Report estimated a
one-year prevalence of major depression at 6.9 %,
equivalent to 30.3 million people in Europe [2]. Women
[3], older adults [4, 5], and people with multimorbidity
[6, 7] are particularly at risk. A review of European com-
munity studies estimated that only 26 % of people with a
mental disorder had sought health care, suggesting a
considerable degree of unmet needs [8].
The World Health Organization (WHO) has recom-
mended integrating mental health care into existing care
settings to increase availability [9]. General practitioners
(GPs) are usually the first encounter depressed people
have with the health service, thus playing a crucial role
in diagnosing and treating depression [10, 11]. In
Norway, several government policies have been imple-
mented that may change the provision of depression
care in general practice. First, the National Program for
Mental Health was implemented from 1999 to 2006
[12], mandating efforts to expand service capacity and
quality in community-based and specialist mental health
services for adults. The program resulted in a significant
capacity shift from psychiatric beds to outpatient ser-
vices [13]. With respect to primary care, low-threshold
mental health services were established in the local com-
munities, such as Healthy Life Centers, psychologists,
outreach teams, and urgent mental health care. Second,
a national guideline for diagnosing and treating adults
with depression in primary and secondary care was pub-
lished in 2009 [14]. While the use of antidepressant
medication has increased dramatically during the 1990s
[15, 16], the Norwegian and UK guidelines emphasize,
e.g., the evidence base for drug treatment [14, 17]. Third,
economic incentives are currently channeled into the
field to stimulate GPs to give more priority to providing
mental health care to their patients, e.g., talking therapy.
Finally, policymakers have addressed the positive mental
health effects of work participation, urging GPs to limit
sick leave certification for patients with mild mental
disorders [18]. Until now, however, little research has
been conducted to ascertain whether and how GP
depression care delivery has changed during the times
of these policy changes.
The treatment of depression mainly consists of
psychological and/or pharmacological interventions [19].
In moderate to severe cases, GPs can refer patients to
secondary mental care provided by psychologists or psy-
chiatrists. In some countries, including Norway, Sweden
and the UK, GPs have an additional key role in certifying
sick leave for patients with reduced work capacity [20].
Recent studies of GP depression care provided in the
Netherlands and the UK indicate trends towards less
prescription of antidepressant medication [21, 22]. How-
ever, time trends in GP depression care in Norway are
poorly documented.
Based on information on all GP encounters and treat-
ments stored in national databases, we examined the
trends in treatment for depression in Norwegian general
practice from 2009 to 2015. Further, we investigated
whether trends varied across patient gender, age, and
comorbidity.
Methods
All residents in Norway have access to the public health
services and prescription drugs (for example antidepres-
sant drugs), covered by the National Insurance Scheme.
A patient list-system was introduced in 2001, entitling
all residents to have a regular GP [23]. The GPs provide
comprehensive care for a broad range of health issues,
and act as gatekeepers to secondary health care and
social security benefits [24].
Design
We conducted a nationwide registry-based cohort study
comprising all individuals with one or more new depres-
sion diagnoses recorded in general practice during
2009–2015. We examined the provision of GP depres-
sion care for 12 months from the date of the depression
diagnosis (index date).
Data sources
Information drawn from national registries for the
period 2008 through 2016 was linked at the individual
patient level and GP level, using the (encrypted) unique
personal identification number assigned to all residents
of Norway. Data was stored and analyzed in a safe server
at the University of Bergen.
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The study population was drawn from the Population
Registry. We obtained complete information regarding
gender, year of birth, death, and emigration for all citi-
zens born before 1989. The Control and Reimbursement
of Health Care Claims (KUHR) database stores data on
all fee-for-service claims from public primary care
providers. For each encounter with a GP, we extracted
information on date of contact, reimbursement code(s)
for diagnostic and therapeutic measures, and one or
more diagnoses according to the International Classifica-
tion of Primary Care 2nd version (ICPC-2), as recorded
by the GPs. The Norwegian Prescription Database
(NorPD) contains information on all prescription drugs
dispensed at pharmacies to individual patients treated in
ambulatory care. For each prescription of a depression
drug, NorPD provided information on date of dispens-
ing, generic drug information (Anatomical Therapeutic
Chemical (ATC) code), and any reimbursement code
linked to specific diagnoses. NorPD lacks information at
the individual level on medication dispensed to people
staying in hospitals or nursing homes. The Norwegian
Patient Registry (NPR) comprises information on all
patient contacts with refundable secondary health care.
We obtained information on date of depression contact
with secondary care providers, with diagnoses according
to the International Classification of Disease 10th revision
(ICD-10). The data extracts provided by the national
registries contained no missing information.
Study population
The source population at risk comprised all residents of
Norway born before 01.01.1996 and alive 01.01.2009 (4,
017,989 individuals). First, we identified all individuals
with one or more depression diagnoses recorded in ge-
neral practice (GP-consultation with the ICPC-2 code
P76 Depression in KUHR) during each year 2008–2015).
Second, to establish a cohort of patients with new de-
pression diagnoses, washout during 12 months prior to
index date was performed for patients with a depression
diagnosis in general practice (P76 in KUHR) or secon-
dary health care (ICD-10 codes F32, F33, F34 or F41.2 in
NPR), and/or dispensed antidepressant medication
(NorPD). The 12-month contact-free interval was de-
fined according to the algorithm published by Nielen
and coworkers [25]. We thus identified 307,237 unique
patients with new diagnoses of depression. Out of these,
51,753 incurred two or more depression episodes that
were at least 12 months apart.
Outcome
Information on GP depression care linked to ICPC-2
code P76 Depression, received during 12 months from
the index date, was included from KUHR. We subse-
quently counted the number of GP consultations during
one year from the index date. Types of depression care
studied were consultations, including long consultations
(i.e., > 20 min), talking therapy, referral to secondary
mental health care, and certification of sickness absence.
Throughout this paper, we use the term ‘talking therapy’
for GPs’ psychological treatment, including supportive
talk, counseling, and structured psychotherapeutic
methods such as cognitive-behavioral therapy [26–28].
Until July 2011, GPs could use the reimbursement code
for talking therapy only if the patient had been referred
to specialist mental health care, and until July 2014, this
code could not be combined with the higher rewarding
reimbursement code for long consultation. Considering
that the latter change may have influenced how GPs use
these reimbursement codes, we also provide combined
figures. The variables were binary (yes, no). In addition,
each variable had information on whether care started at
the index consultation or if it started during follow-up.
We investigated certification of sickness absence among
patients between 20 and 66 years of age (at index date).
From NorPD, we included all antidepressant drugs
(ATC code N06A) reimbursed by the Norwegian State
for the treatment of depression, dispensed during 12
months from the index date (yes, no).
Covariates
Gender (women, men). We recoded patient age into two
groups, 20–66 years (working-aged) and 67 + years. Pre-
existing comorbidity was categorized as no pre-existing
comorbidity, somatic only, mental only, or both somatic
and mental health condition(s) [6].
Statistical analysis
The annual incidence of patients recorded with a new
depression diagnosis in general practice was calculated
for gender and age groups, with the population aged
20 + as the denominator. Mean numbers of consultations
with standard deviation (SD) were calculated for each
year. In addition, consultation was divided into three
groups (‘index date only’, ‘1–2’ or ‘3 or more’ follow-up
consultations), and rates with a 95 % confidence interval
(CI) were provided. Frequency of each type of GP de-
pression care (talking therapy, long consultation, talking
therapy and/or long consultation, referral to secondary
care, sick leave certification among 20-66-year-olds)
starting at index date, or after index date was calculated
with a 95 % CI. Rate and 95 % CI of antidepressant drug
treatment was established.
We defined a ‘GP-consultation-population’ compris-
ing all GP consultations regardless of diagnosis, re-
corded in the KUHR database in the study period.
We used this population to calculate the proportion
of each type of treatment in consultations with a de-
pression diagnosis and in consultations with other
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diagnoses, by year (panel a). For the study population,
treatment rate and 95 % CI of each type of treatment,
by year of depression diagnosis, were presented as
graphs by gender (panel b), age group (panel c), and
comorbidity (panel d). Antidepressant use in the gen-
eral population [29] and in patients with depression
was presented as graphs (panel a). Antidepressant use
in the study population was also presented for each
of the covariates (panel b-d).
For each treatment type, a generalized linear model
(GLM) was used to test for linear time trends. Further,
the time trend for each value of the covariate was tested,
and in addition, the interaction between year and the co-
variate was tested. To evaluate the significance of the
test results, a level of α = 0.001 was applied. We provide
the results of all tests by p-values in Supplementary
Table 1. The data were analyzed using STATA/SE ver-
sion 16.1 (Stata Statistical Software).
Results
The study comprised 365,947 new depression diagnoses
in 307,237 unique patients. Mean patient age at index
date was 44.3 years (SD = 15.9; men: 43.7 (15.1); women:
44.6 (16.4)), and 61.9 % were women. Most patients were
of working age (90.7 %) and 41.3 % had pre-existing co-
morbidity (27.0 % somatic, 9.3 % mental, 5.0 % both).
The annual incidence of GP-recorded depression was
1.46 % in 2009 and decreased slightly to 1.34 % in 2015.
For the whole period, the incidence was 1.8 % among
women and 1.1 % among men. Figure 1 provides age-
and year-specific depression incidence for genders
separately.
The mean number of GP consultations for depression
was stable throughout the study period; this also applied
for having an index consultation only, 1–2 follow-up
consultation(s), and 3 or more follow-up consultations,
respectively (Table 1).
The provision of talking therapy in a consultation
increased during the study period (Fig. 2a). In terms
of treatment rates for depression, talking therapy
starting at index consultation increased from 27.0 %
to 2009 to 51.1 % in 2015, while talking therapy start-
ing during follow-up was stable over the years
(Table 1). Women had a larger increase in talking
therapy provision compared to men (Fig. 2b). A larger
Fig. 1 Annual incidence of patients recorded with a new depression diagnosis in general practice, by gender and age group
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proportion of working-aged patients had talking ther-
apy with the GP compared to patients aged 67+.
However, the latter group had a greater increase in
talking therapy during the first few years than the
younger patients (Fig. 2c). Patients without comorbid-
ity or with somatic comorbidity received less talking
therapy early in the study period and gradually more
in later years, reaching a similar level as those with
comorbid mental conditions (Fig. 2d).
Long consultations (i.e., > 20 min) increased during
the study period, and the increase was pronounced from
2013 to 2015 for consultations with a depressed patient
(Fig. 3a). For patients with a new depression diagnosis,
the rates of long consultations starting at index consul-
tation increased mainly in the last two years of the
period, while long consultations starting during follow-
up were stable (Table 1). The time trends for long con-
sultations were similar for genders (Fig. 3b). Patients
aged 67 + had higher rates of long consultations from
2009 to 2012, and from 2013, both age groups had in-
creasing rates (Fig. 3c). Those with somatic comorbidity
or without comorbidity had higher rates of long
consultations compared to those with mental comorbid-
ity, but differences became less pronounced towards the
end of the study period (Fig. 3d).
The combination of talking therapy and/or long con-
sultation starting at index consultation increased grad-
ually over the years (Table 1).
There was a weak increase over the years to refer a pa-
tient to specialist mental health care in a consultation, both
for depressed patients and patients with other diagnoses
(Fig. 4a). For patients with depression, the referral rates at
index date and during follow-up increased gradually
(Table 1). Men, working-aged patients, and those without
comorbidity were more commonly referred compared to
women, those aged 67+, and patients with comorbidity, re-
spectively (Fig. 4b and d). However, there were no inter-
actions between year and any of the covariates.
The proportion of depressed patients who were
dispensed antidepressant drugs decreased from
31.3 % to 2009 to 25.9 % in 2015 (Table 1; Fig. 5a).
Men had slightly higher treatment rates compared to
women, but the time trends were similar for genders
(Fig. 5b). For patients aged 67+, the decrease in
Fig. 2 Talking therapy by year. a GP population: proportion of talking therapy in consultations with a depression diagnosis, and consultations
with other diagnoses. b-d Study population: treatment rate and 95% CI during one-year follow up by b gender, c age group and d comorbidity
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antidepressant use was more pronounced (from 52 %
to 2009 to 40 % in 2015) than for working-aged pa-
tients (Fig. 5c). Drug treatment decreased among all
categories of comorbidity, and the trends were simi-
lar (Fig. 5d).
Sick-listing by GP, regardless of diagnosis, de-
creased from 2009 to 2010 (Fig. 6a). For depressed
patients, sick leave certified at index consultation de-
creased from 47.5 % to 2009 to 39.2 % in 2015.
About 10 % of the patients were sick-listed during
follow-up, and this percentage did not change
throughout the period (Table 1). A greater share of
women than men was sick-listed, and the decrease
was more pronounced in men over the years
(Fig. 6b). There was a reduction over time in sick
leave certification for patients without comorbidity
or with somatic comorbidity only. For those with
mental comorbidity, sickness absence certification
was lower than for other groups but did not change
over time, and there was no interaction between year
and comorbidity (Fig. 6c).
Discussion
Summary
In a nationwide cohort of patients with one or more new
depression diagnoses, we examined time trends in depres-
sion care provided by the GP from 2009 to 2015. The
one-year incidence rates of depression recorded in general
practice decreased slightly during the study period. With
respect to type of GP care, we found trends towards more
provision of talking therapy, more long consultations, and
more referral to secondary care, whereas drug treatment
and sick-listing decreased over time. The time trends
were different for gender (women had a greater in-
crease in talking therapy and a smaller decrease in
sick-listing, compared to men), age (working-aged pa-
tients had a smaller increase in talking therapy, a
greater increase in long consultations, and a smaller
decrease in antidepressant drug use, compared to
older patients) and comorbidity (patients with mental
comorbidity had a smaller increase in talking therapy
and a greater increase in long consultations, com-
pared to no comorbidity and somatic comorbidity).
Fig. 3 Long consultation (> 20 minutes) by year. a GP population: proportion of long consultations (> 20 minutes) in consultations with a
depression diagnosis, and consultations with other diagnoses. b-d Study population: treatment rate and 95% CI during one-year follow up by
b gender, c age group and d comorbidity
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Strengths and limitations
The main strength of this study is the use of complete
registry data from the publicly subsidized primary care ser-
vices in Norway. Linked data from five national health- and
population registries at the individual patient level provides
a unique source of information, elimina-ting recall bias.
We defined a new depression diagnosis as a GP-
consultation with the ICPC-2 code P76, after a one-year
wash-out. However, our population was restricted to pa-
tients whose depression was identified by the GP and re-
corded as such. Patients with depression who did not
seek help or were not diagnosed with depression by the
GP remained beyond our scope. Further, information on
the severity of depression was lacking, as ICPC-2 does
not allow for such grading.
A limitation of using the reimbursement code for talking
therapy was that the prerequisites were changed during the
study period. The recorded reimbursement codes probably
did not catch all performed GP talking therapy sessions, be-
cause referral to secondary mental care was a requirement
until July 2011, and until July 2014, this code could not be
combined with the higher rewarding reimbursement code
for a long consultation (> 20 min).
The NorPD contains complete data on all prescription
drugs dispensed, thus we may have slightly underesti-
mated the prevalence of prescribed antidepressants. To
strengthen the internal validity, we have considered anti-
depressants reimbursed for the treatment of depression
only. No information was available on the appropriate-
ness of the different types of treatment provided.
The results of this study could be transferable to
countries where GPs fulfill comparable roles to the
Norwegian GPs (having fixed, personalized patient lists,
and acting as gatekeepers), such as Sweden, the UK, and
the Netherlands. They are less comparable with countries
where GPs have different task assignments.
Interpretation of findings and comparison with existing
literature
Patient population recorded with depression in general practice
The gender distribution in our study population is
consistent with previous research [30], reflecting a higher
Fig. 4 Referral to secondary care by year. GP population: proportion of referral to secondary care in consultations with a depression diagnosis,
and consultations with other diagnoses. b-d Study population: treatment rate and 95% CI during one-year follow up by b gender, c age group
and d comorbidity
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prevalence of depression [3] and more doctor-seeking [31]
among women compared to men. Although older people
are at greater risk of depression [4, 5], we found that the
annual incidence of GP-recorded depression decreased with
increasing age (Fig. 1). This may reflect that the
course of depression becomes more prolonged / chronic
with increasing age. Also, older people are less inclined to
seek help for their psychological problems [32].
The decrease in annual incidence rate of GP-recorded
depression is consistent with trends reported in the UK
[33]. This change occurred in the context of increasing
availability of low-threshold mental health services in
the local communities and self-guided internet-based in-
terventions. This raises the question whether people
have changed their health care-seeking behavior, i.e.,
those with more severe depression seek their GP while
those with less severe depression use the newly
established low-threshold services instead. However, the
Norwegian health registries do not include information
at the individual level about the provision of low-
threshold services for depressed people. Further, the
observed time trend to refer more patients, coinciding
with increasing capacity in outpatient secondary mental
care [13], was likely attributable to a selection of patients
with more severe depression (in need of referral) and/or
GPs’ altered referral behavior.
Time trends in GP-depression care
Although there was a substantial increase in long
consultations, the mean number of GP follow-up
consultations did not change over time. In compari-
son, numbers of GP contacts for depression in the
Netherlands increased after implementing a stepped
collaborative depression programme [34] and integra-
ting mental health nurses in primary care teams [35].
So far, however, such targeted initiatives have not
been implemented in Norway.
Our findings indicate that provision of talking therapy
increased, while antidepressant drug treatment de-
creased over time. These changes occurred following the
publication of national guidelines that encourage
improved targeting of drug treatment for depression and
Fig. 5 Antidepressant drug treatment by year. a Proportion of antidepressant drug use among patients with a depression diagnosis, and of the
general population aged 20+. b-d Study population: treatment rate and 95% CI during one-year follow up by b gender, c age group
and d comorbidity
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emphasize psychological treatment as GPs’ primary tool
in depression care [14]. Further, GPs’ increasing
provision of talking therapy and long consultations during
the last years of the study was likely attributable (in part)
to a change in the terms in mid-2014, i.e., both tariffs
could be used together. Finally, patient preferences may
be drivers of change as patients increasingly partici-
pate in the decision-making about their health care
[36]. Notably, a meta-analytic review across different
settings yielded a 70 % greater patient preference for psy-
chological treatment than for pharmacological treatment
for depression [37].
From an international perspective, GPs’ antidepressant
prescribing rates in the Netherlands (2011–2015) de-
creased more than in Norway [21], while prescribing
rates in the UK (2003–2013) declined only for first-ever
depression episodes [22]. In US outpatient treatment of
depression (2007–2015), the use of psychotherapy
increased, while drug treatment remained stable [38].
Generally, the 26-31 % antidepressant prescribing rates
found in this study are considerably lower than the 45-
75 % rates reported in European countries with compar-
able primary care systems like the UK, the Netherlands,
and Sweden [21, 22, 30]. This discrepancy may be due to
the strict definitions of antidepressant drugs (excluding
prescriptions issued for other diagnoses than depression)
and drug dispensing data in this study.
The observed decrease over time in GPs’ sick leave certi-
fication was attributable to less sick-listing starting at index
date. This trend is in accordance with Norwegian govern-
ment policy [18] and European policy [39], urging GPs to
limit certification of sick leave in patients with mild mental
disorders. Studies indicate that mental disorders have
gradually replaced musculoskeletal problems as the
main cause of sickness certification [40], with depres-
sion as the leading cause of GPs’ sickness certification
related to common mental disorders [41]. Possibly,
intensified GP depression care in terms of more talk-
ing therapy and long consultation have contributed to
reducing sickness absence [42].
Fig. 6 Sick leave certification among patients 20-66 years old, by year. a GP population: proportion of sick leave certification in consultations with
a depression diagnosis, and consultations with other diagnoses. b-c Study population: treatment rate and 95% CI during one-year follow up by
b gender and c comorbidity
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Time trends related to patient gender, age, and comorbidity
Men were slightly more likely to receive drug treatment
and slightly less likely to be sick-listed, compared to
women, consistent with previous research [29, 41, 43].
The greater proportion of women than men receiving
talking therapy or long consultations with the GP, and the
greater increase in talking therapy among women may be
related to gendered patient preferences, i.e., women ex-
press and talk about their feelings more easily [44].
Greater referral rates and antidepressant prescription rates
among men compared to women, may relate to less
doctor-seeking [31], and more severe depression at
diagnosis date.
The greater increase among older patients compared to
working-aged patients has reduced but not eliminated the
age gap regarding the provision of talking therapy. Also,
referral rates for depressed patients aged 67 + were persist-
ently lower than for working-aged patients, in line with
findings in a comparable study in the UK [45]. An explan-
ation of the observed age gap in psychological treatment
in general practice and referral to secondary care may be
that older people wish to solve their emotional problems
autonomously and fear of stigma [46]. However, a system-
atic review of qualitative studies indicates that older
people express preferences for talking therapies [47]. Fur-
ther, the considerably higher antidepressant prescription
rates for older patients than working-aged patients ob-
served in this study are consistent with the beforemen-
tioned study in the UK [45]. Although the drug treatment
rate for older patients decreased over time, it remained
significantly higher than for patients of working age. This is
of concern because antidepressants are associated with ad-
verse events, such as falls and stroke, in older people [48].
The higher antidepressant treatment rate in patients
with somatic comorbidity compared to those with mental
comorbidity or without comorbidity was a surprising find-
ing. Comparable studies of patients newly diagnosed with
depression in general practice revealed higher prescription
rates for Dutch patients with chronic somatic or psychi-
atric comorbidity [49], while prescription rates in the UK
were lower for patients with comorbid so-matic illness
[50], compared to those without comorbidity. Smolders
et al. point out that GPs have higher contact rates with pa-
tients who suffer from multimorbidity and thus have more
opportunities to treat their depression [49]. Further, our
findings indicate that patients without comorbidity or with
somatic comorbidity were more easily sick-listed than
those with mental comorbidity. This difference may be at-
tributable to patients with several mental conditions hav-
ing more long-term periods of sick-leave, i.e., being not at
risk of being sick-listed when a new depression episode
starts. Also, GPs may have limited sick-listing of patients
with mild mental disorders, in line with Norwegian [18]
and European po-licy [39].
Implications for research and/or practice
The European Mental Health Action Plan 2013–2020
emphasized the importance of integrating mental health
care into the general health care setting [9]. Worldwide,
many initiatives have been undertaken to promote the
substitution of mental health care from specialized care,
e.g., provision of psychological treatment by the GP [27,
28]. Our findings support that most patients diag-nosed
with depression by the GP are treated within general
practice, in line with previous research [11]. The
provision of talking therapy and long consultations in-
creased substantially, in accordance with government pol-
icy in Norway. However, the average number of GP
consultations for depression was unchanged. This may
point at sustainability is being challenged because general
practice as a service level has not been strengthened
through the National Program for Mental Health [12] or
other recent reforms.
Conclusions
The observed time trends in GP depression care towards
more provision of psychological treatment, and less
provision of pharmacological treatment and sick-leave
certification were in the desired direction according to
Norwegian health care policy. However, the large and
persistent differences in treatment rates between
working-aged and older patients is of concern. We have
planned follow-up studies to examine the reasons for
these differences. Further, clinical studies are needed to
explore the implications of the observed changes for
patient outcomes.
Abbreviations
ATC: Anatomical Therapeutic Chemical; CI: Confidence interval;
GLM: Generalized Linear Model; GP: General practitioner; ICD: International
Classification of Disease; ICPC: International Classification of Primary Care;
KUHR: Control and Reimbursement of Primary Health Care Claims Database;
NorPD: Norwegian Prescription Database; NPR: Norwegian Patient Registry;
WHO: World Health Organisation; YLD: Years lived with disability
Supplementary Information




We thank Tatiana Fomina at Biostatistics and Data analysis core facility (BIOS)
at the University of Bergen for help in facilitating data. We acknowledge
Heidi Marie Meling for English language editing.
Authors’ contributions
SR, VB, IH, ØH, and TSS defined the research question, designed the study,
and interpreted the results. SR and IH obtained approvals and acquired data.
VB conducted the statistical analyses. SR and VB wrote the main manuscript
text. VB prepared Table 1; Figs. 1, 2, 3, 4, 5 and 6. All authors reviewed the
manuscript and approved the final version.
Ruths et al. BMC Health Services Research          (2021) 21:697 Page 11 of 13
Funding
Research Council of Norway (Grant number 287884).
Availability of data and materials
The data underlying this article were provided by the Norwegian Directorate
of Health, the Norwegian Institute of Public Health, and Statistics Norway by
permission. The data cannot be shared publicly due to restrictions by the
Norwegian Data Protection Authority.
Declarations
Ethics approval
The study protocol has been approved by the Regional Committee for
Medical and Health Research Ethics (REC) West (2017/934) and by the
Norwegian Data Protection Authority (17/01372). This study used de-
identified administrative health care data from national registries, and REC
West granted an exemption from the consent requirement (2017/934). All





The authors declare that they have no competing interests.
Author details
1Research Unit for General Practice, NORCE Norwegian Research Centre,
Årstadveien 17, N-5009 Bergen, Norway. 2Department of Global Public Health
and Primary Care, University of Bergen, Bergen, Norway. 3Division of
Psychiatry, Haukeland University Hospital, Bergen, Norway.
Received: 24 March 2021 Accepted: 30 June 2021
References
1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.
Global, regional, and national incidence, prevalence, and years lived with
disability for 354 diseases and injuries for 195 countries and territories,
1990–2017: a systematic analysis for the Global Burden of Disease Study
2017. Lancet. 2018;392:1789–1858.
2. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, et al.
The size and burden of mental disorders and other disorders of the brain in
Europe 2010. Eur Neuropsychopharmacol. 2011;21:655–79.
3. Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, et al. Global
variation in the prevalence and incidence of major depressive disorder: a
systematic review of the epidemiological literature. Psychol Med. 2013;43:471–81.
4. Alexopoulos GS. Depression in the elderly. Lancet. 2005;365:1961–70.
5. Rodda J, Walker Z, Carter J. Depression in older adults. BMJ. 2011;343:d5219.
6. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology
of multimorbidity and implications for health care, research, and medical
education: a cross-sectional study. Lancet. 2012;380:37–43.
7. Read JR, Sharpe L, Modini M, Dear BF. Multimorbidity and depression: A
systematic review and meta-analysis. J Affect Disord. 2017;221:36–46.
8. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe – a critical
review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005;15:357–76.




10. Verhaak PF, van Dijk CE, Nuijen J, Verheij RA, Schellevis FG. Mental health
care as delivered by Dutch general practitioners between 2004 and 2008.
Scand J Prim Health Care. 2012;30:156–62.
11. Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ,
et al. Use of mental health services for anxiety, mood, and substance
disorders in 17 countries in the WHO world mental health surveys. Lancet.
2007;370:841–50.
12. Ministry of Health and Care Services. Opptrappingsplanen for psykisk helse
(1999–2008). St.prp. nr. 63 (1997–98). [National Program for Mental Health].
https://www.regjeringen.no/no/dokumenter/stprp-nr-63-1997-98-/id201915/
Accessed 23 Mar 2021.
13. The Norwegian Research Council. Evaluering av Opptrappingsplanen for
psykisk helse (2001–2009). [Evaluation of the National Program for Mental
Health (2001–2009)]. ISBN 978-82-12-02678-0. Oslo, 2009
14. Norwegian Board of Health. Nasjonale retningslinjer for diagnostisering og
behandling av voksne med depresjon (IS-1561). Oslo: National guidelines for
diagnosis and treatment of adults with depression; 2009.
15. Brugha TS, Bebbington PE, Singleton N, Melzer D, Jenkins R, Lewis G, et al.
Trends in service use and treatment for mental disorders in adults
throughout Great Britain. Br J Psychiatry. 2004;185:378–84.
16. Mojtabai R. Increase in antidepressant medication in the US adult
population between 1990 and 2003. Psychother Psychosom. 2008;77:83–92.
17. National Institute for Health and Clinical Excellence (NICE), 2009. Depression
in adults: recognition and management. Clinical Guideline CG90. https://
www.nice.org.uk/guidance/cg90/resources/depression-in-adults-
recognition-and-management-pdf-975742636741 Accessed 23 Mar 2021.
18. The Norwegian Directorate of Health. Sykmelderveileder. [Norwegian
guideline for sickness absence certification] https://www.helsedirektoratet.
no/veiledere/sykmelderveileder Accessed 23 Mar 2021.
19. Ramanuj P, Ferenchick EK, Pincus HA. Depression in primary care: part 2-
management. BMJ. 2019;365:l835.
20. Macdonald S, Maxwell M, Wilson P, Smith M, Whittaker W, Sutton M, et al. A
powerful intervention: general practitioners’ use of sickness certification in
depression. BMC Fam Pract. 2012;13:82.
21. Magnée T, de Beurs DP, Schellevis FG, Verhaak PF. Antidepressant prescriptions
and mental health nurses: an observational study in Dutch general practice
from 2011 to 2015. Scand J Prim Health Care. 2018;36:47–55.
22. Kendrick T, Stuart B, Newell C, Geraghty AW, Moore M. Did NICE guidelines
and the Quality Outcomes Framework change GP antidepressant
prescribing in England? Observational study with time trend analyses 2003–
2013. J Affect Disord. 2015;186:171–7.
23. The Norwegian Ministry of Health and Care Services. The introduction of a
regular general practitionaer scheme. Oslo, 2001. https://www.regjeringen.
no/en/dokumenter/regulation-relating-to-a-municipal-regul/id420530/
Accessed 18 Feb 2021.
24. Lindahl AK, Ringard A. The Norwegian Health System 2013. In:
International profiles of health care systems (pp.104–112). Edition:
Report no. 1717. Publisher: The Commonwealth Fund. Ed: Thompson S,
Osborn R, Squires D, Jun M.
25. Nielen MMJ, Spronk I, Davids R, Korevaar JC, Poos R, Hoeymans N, Opstelten
W, van der Sande MAB, Biermans MCJ, Schellevis FG, Verheij RA. Estimating
morbidity rates based on routine electronic health records in primary care:
observational study. JMIR Med Inform. 2019;26(3):e11929.
26. NHS Health Scotland. Talking Therapies Explained. 2018. https://www.
nhsinform.scot/healthy-living/mental-wellbeing/therapy-and-counselling/ta
lking-therapies-explained Accessed 18 Feb 2021.
27. Bower P, Knowles S, Coventry PA, Rowland A. Counselling for mental health
and psychosocial problems in primary care. Cochrane Database Syst Rev.
2011;9:CD001025.
28. Cape J, Whittington C, Buszewicz M, Wallace P, Underwood L. Brief
psychological therapies for anxiety and depression in primary care: meta-
analysis and meta-regression. BMC Med. 2010;8:38.
29. Norwegian Institute of Public Health. The statistical database for prescription
drug dispensing: https://www.fhi.no/en/hn/health-registries/norpd/
Accessed 23 Mar 2021.
30. Lytsy P, Hallqvist J, Alexanderson K, Åhs A. Gender differences in healthcare
management of depression: aspects of sick leave and treatment with
psychoactive drugs in a Swedish setting. Nord J Psychiatry. 2019;73:441–50.
31. Wang Y, Hunt K, Nazareth I, Freemantle N, Petersen I. Do men consult less
than women? An analysis of routinely collected UK general practice data.
BMJ Open. 2013;3:e003320.
32. Dorow M, Löbner M, Pabst A, Stein J, Riedel-Heller SG. Preferences for
depression treatment including internet-based Interventions: Results from a
large sample of primary care patients. Front Psychiatry. 2018;9:181.
33. Kendrick T, Stuart B, Newell C, Geraghty AW, Moore M. Changes in rates of
recorded depression in English primary care 2003–2013: Time trend
analyses of effects of the economic recession, and the GP contract quality
outcomes framework (QOF). J Affect Disord. 2015;180:68–78.
34. Gidding LG, Spigt MG, Dinant GJ. Stepped collaborative depression care:
primary care results before and after implementation of a stepped
collaborative depression programme. Fam Pract. 2014;31:180–92.
Ruths et al. BMC Health Services Research          (2021) 21:697 Page 12 of 13
35. Magnée T, de Beurs DP, de Bakker DH, Verhaak PF. Consultations in general
practices with and without mental health nurses: an observational study
from 2010 to 2014. BMJ Open. 2016;6:e011579.
36. Hopwood M. The shared decision-making process in the pharmacological
management of depression. Patient. 2020;13:23–30.
37. McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient
preference for psychological vs pharmacologic treatment of psychiatric
disorders: a meta-analytic review. J Clin Psychiatry. 2013;74:595–602.
38. Hockenberry JM, Joski P, Yarbrough C, Druss BG. Trends in treatment and
spending for patients receiving outpatient treatment of depression in the
United States, 1998–2015. JAMA Psychiatry. 2019;76:810–7.
39. OECD. Mental Health and Work. Fit mind, fit job: From evidence to practice
in mental health and work. Paris, France: OECD Publishing; 2015.
40. Harvey SB, Joyce S, Modini M, Christensen H, Bryant R, Mykletun A, et al.
Work and depression/ anxiety disorders – a systematic review of reviews:
final report. Melbourne, Australia: Beyondblue; 2013.
41. Gjesdal S, Holmaas TH, Monstad K, Hetlevik Ø. GP consultations for
common mental disorders and subsequent sickness certification:
registerbased study of the employed population in Norway. Fam Pract.
2016;33:656–62.
42. Rost K, Smith JL, Dickinson M. The effect of improving primary care
depression management on employee absenteeism and productivity. A
randomized trial. Med Care. 2004;42:1202–10.
43. Mallen CD, Wynne-Jones G, Dunn KM. Sickness certification for mental
health problems: an analysis of a general practice consultation database.
Prim Health Care Res Dev. 2011;12:179–82.
44. Houle J, Villaggi B, Beaulieu MD, Lespérance F, Rondeau G, Lambert J.
Treatment preferences in patients with first episode depression. J Affect
Disord. 2013;147:94–100.
45. Walters K, Falcaro M, Freemantle N, King M, Ben-Shlomo Y.
Sociodemographic inequalities in the management of depression in adults
aged 55 and over: an analysis of English primary care data. Psychol Med.
2018;48:1504–13.
46. Kitchen KA, McKibbin CL, Wykes TL, Lee AA, Carrico CP, McConnell KA.
Depression treatment among rural older adults: Preferences and factors
influencing future service use. Clin Gerontol. 2013;36:10.
47. Frost R, Beattie A, Bhanu C, Walters K, Ben-Shlomo Y. Management of
depression and referral of older people to psychological therapies: a
systematic review of qualitative studies. Br J Gen Pract. 2019;69:e171-e181.
48. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J.
Antidepressant use and risk of adverse outcomes in older people:
population based cohort study. BMJ. 2011;343:d4551.
49. Smolders M, Laurant M, van Rijswijk E, Mulder J, Braspenning J, Verhaak P,
et al. Depressed and a co-morbid condition: more psychotropics prescribed!
Eur J Gen Pract. 2008;14:10–8.
50. Kendrick T, Dowrick C, McBride A, Howe A, Clarke P, Maisey S, et al.
Management of depression in UK general practice in relation to scores on
depression severity questionnaires: analysis of medical record data. BMJ.
2009;338:b750.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Ruths et al. BMC Health Services Research          (2021) 21:697 Page 13 of 13
